Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.
Idiopathic erythema multiforme: Evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.
复制标题
DOI:
10.1016/j.jdcr.2016.10.009
复制
发表时间:
2016-11
影响因子:
--
通讯作者:
King BA
中科院分区:
文献类型:
--
作者:
Damsky W;King BA
Erythema multiforme (EM) is an acute, typically self-limited mucocutaneous eruption characterized by distinctive target lesions. In a subset of patients, EM has a more chronic course, with recurrent episodes or even persistent disease. In some of these patients, EM is related to chronic infections, most commonly herpes simplex virus (HSV), and will respond to antiviral therapy. However, in up to 58% of patients, the etiology is unknown, 1 and in these cases treatment is often difficult.